Physician

Weiping Zang, M.D

According to 2025 Medicare claims, Weiping Zang, M.D (NPI: 1366722787) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (NPI: 1891065256; TIN: 452681845) and primary practice location at 45249-2309. Zang is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Zang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 290 traditional Medicare patients, billed 75,671 HCPCS/CPT codes, and received $1,798,096 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 938 prescription claims across 149 beneficiaries totaling $3,098,961 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 22 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $69,496 to $1,798,096. Similarly, Part D prescription costs have moved sharply higher in recent years, from $58,708 to $3,098,961. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	162	3,044	$69,496
2016	214	12,019	$196,378
2017	255	19,214	$412,944
2018	280	64,256	$716,690
2019	308	90,306	$979,353
2020	293	84,232	$1,349,301
2021	235	65,224	$1,145,902
2022	250	84,721	$1,508,830
2023	250	68,314	$1,127,316
2024	290	75,671	$1,798,096

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	48	283	$58,708
2016	63	450	$147,526
2017	97	552	$322,326
2018	135	896	$746,319
2019	127	922	$771,677
2020	139	950	$1,285,539
2021	125	803	$1,234,709
2022	146	1,027	$1,788,408
2023	146	857	$2,187,122
2024	149	938	$3,098,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$935
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	22	$889
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	36	92	$130
96413	Administration of chemotherapy into vein, 1 hour or less	35	201	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	228	$91
96372	Injection of drug or substance under skin or into muscle	39	103	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	101	287	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	30	840	$696,361
Jakafi	Ruxolitinib Phosphate	23	690	$400,135
Calquence	Acalabrutinib Maleate	23	690	$356,278
Lenalidomide	Lenalidomide	19	532	$272,937
Pomalyst	Pomalidomide	11	280	$215,229

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$22	Tempus AI, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Weiping Zang, M.D?

Tedicare shows public-source Medicare data for Weiping Zang, M.D (NPI 1366722787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Weiping Zang, M.D have ACO affiliation data?

Weiping Zang, M.D is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Weiping Zang, M.D?

Weiping Zang, M.D is linked to CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (billing NPI 1891065256) in the available physician profile data.

Does Weiping Zang, M.D have Open Payments data?

Weiping Zang, M.D has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.